Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Takahito Suto, Yukio Yonemoto, Koichi Okamura, Hideo Sakane, Kimihiko Takeuchi, Yasuyuki Tamura, Tetsuya Kaneko, Keio Ayabe & Hirotaka Chikuda. (2019) The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis. Modern Rheumatology 29:5, pages 775-781.
Read now
Read now
Koichiro Ishikawa & Junichiro Ishikawa. (2019) Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years’ treatment for Japanese rheumatoid arthritis patients. Modern Rheumatology 29:3, pages 418-429.
Read now
Read now
Yuki Arita, Hiroaki Taguchi, Mari Kobayashi, Toshihiro Tono, Yasuo Ohsone & Yutaka Okano. (2018) pneumonia developed in a patient with rheumatoid arthritis after 14 weeks of iguratimod add-on to treatment with methotrexate and etanercept. Modern Rheumatology 28:6, pages 1041-1043.
Read now
Read now
N Zheng, C Guo & R Wu. (2018) Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate–cyclosporin A–hydroxychloroquine–prednisone. Scandinavian Journal of Rheumatology 47:5, pages 422-424.
Read now
Read now
Ayaka Yoshikawa, Shuzo Yoshida, Yuko Kimura, Nao Tokai, Yohei Fujiki, Takuya Kotani, Yoko Matsumura, Tohru Takeuchi & Shigeki Makino. (2018) Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study. Modern Rheumatology 28:2, pages 227-234.
Read now
Read now
Karen J. Wedekind, Kevin J. Ruff, Cindy A. Atwell, Joseph L. Evans & Alison M. Bendele. (2017) Beneficial effects of natural eggshell membrane (NEM) on multiple indices of arthritis in collagen-induced arthritic rats. Modern Rheumatology 27:5, pages 838-848.
Read now
Read now
Ryosuke Kamei, Masanori Kono, Yukiko Iwasaki, Hirofumi Shoda, Kanae Kubo, Keishi Fujio & Kazuhiko Yamamoto. (2017) Iguratimod-induced acute interstitial pneumonia with hypogammaglobulinemia in a rheumatoid arthritis patient. Modern Rheumatology Case Reports 1:2, pages 54-59.
Read now
Read now
Articles from other publishers (15)
Liuting Zeng, Qi He, Ying Deng, Yuwei Li, Junpeng Chen, Kailin Yang, Yanfang Luo, Anqi Ge, Xiaofei Zhu, Zhiyong Long & Lingyun Sun. (2023) Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials. Frontiers in Pharmacology 14.
Crossref
Crossref
Liuting Zeng, Qi He, Kailin Yang, Wensa Hao, Ganpeng Yu & Hua Chen. (2022) A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials of Iguratimod Combined With Other Therapies for Sjogren’s Syndrome. Frontiers in Immunology 13.
Crossref
Crossref
Liuting Zeng, Ganpeng Yu, Kailin Yang, Wensa Hao & Hua Chen. (2022) The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial. Frontiers in Pharmacology 12.
Crossref
Crossref
Sajan Shrestha, Jing Zhao, Changqing Yang & Jinping Zhang. (2021) Iguratimod combination therapy compared with methotrexate monotherapy for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Clinical Rheumatology 40:10, pages 4007-4017.
Crossref
Crossref
Yuji Nozaki. (2021) Iguratimod: Novel Molecular Insights and a New csDMARD for Rheumatoid Arthritis, from Japan to the World. Life 11:5, pages 457.
Crossref
Crossref
Asuka Inoue, Yuji Nozaki, Yasuaki Hirooka, Koji Kinoshita, Yasutaka Chiba, Masanori Funauchi & Itaru Matsumura. (2020) The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care. Life 10:11, pages 261.
Crossref
Crossref
Jie Li, Jun Bao, Jian Zeng, Aizhu Yan, Chunqiu Zhao & Qiang Shu. (2019) Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology. Bone Research 7:1.
Crossref
Crossref
Chak Sing Lau, Faith Chia, Leonila Dans, Andrew Harrison, Tsu Yi Hsieh, Rahul Jain, Seung Min Jung, Mitsumasa Kishimoto, Ashok Kumar, Khai Pang Leong, Zhanguo Li, Juan Javier Lichauco, Worawit Louthrenoo, Shue Fen Luo, Rong Mu, Peter Nash, Chin Teck Ng, Bagus Suryana, Linda Kurniaty Wijaya & Swan Sim Yeap. (2019) 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis. International Journal of Rheumatic Diseases 22:3, pages 357-375.
Crossref
Crossref
. (2018) 関節リウマチ治療におけるイグラチモドの有用性と安全性. Orthopedics & Traumatology 67:2, pages 296-299.
Crossref
Crossref
Jinglue Song, Hongli Liu, Qi Zhu, Yutong Miao, Feiyan Wang, Fan Yang, Wenjing Cheng, Yebin Xi, Xiaoyin Niu, Dongyi He & Guangjie Chen. (2018)
T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-
κ
B
. BioMed Research International 2018, pages 1-8.
Crossref
Crossref
Feng Xiao, Feng Zhang, Ling-ling Zhang & Wei Wei. (2017) A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers. European Journal of Clinical Pharmacology 74:1, pages 69-77.
Crossref
Crossref
Ying‑Xing Wu, Yue Sun, Ya‑Ping Ye, Peng Zhang, Jia‑Chao Guo, Jun‑Ming Huang, Xing‑Zhi Jing, Wei Xiang, Shi‑Ying Yu & Feng‑Jing Guo. (2017) Iguratimod prevents ovariectomy‑induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator‑activated receptor‑γ. Molecular Medicine Reports.
Crossref
Crossref
Yue Sun, Ying-Xing Wu, Peng Zhang, Guang Peng & Shi-Ying Yu. (2017) Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat model. Oncology Letters 13:6, pages 4849-4856.
Crossref
Crossref
Joshua Bloom, Christine Metz, Saisha Nalawade, Julian Casabar, Kai Fan Cheng, Mingzhu He, Barbara Sherry, Thomas Coleman, Thomas Forsthuber & Yousef Al-Abed. (2016) Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential. Journal of Biological Chemistry 291:51, pages 26502-26514.
Crossref
Crossref
. (2015) Iguratimod. Reactions Weekly 1568:1, pages 155-155.
Crossref
Crossref